daptomycin
- Product NDC
- 69097-850
- 11-digit product format
- 690970850
- Labeler code
- 69097
- Product ID
- 69097-850_219e8987-0f88-4149-80e3-77d97e555791
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- daptomycin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Cipla USA Inc.
- Application
- ANDA213425
- Marketing category
- ANDA
- Marketing start
- 2021-03-26
- Marketing end
- 0000-00-00
- Substance
- DAPTOMYCIN
- Active strength
- 350 mg/7mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC],Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-850 | DAPTOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CIPLA USA INC.] | 1 | Legacy NDC | 20210327_219e8987-0f88-4149-80e3-77d97e555791.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-850-67 | 69097085067 | 1 VIAL in 1 CARTON (69097-850-67) > 7 mL in 1 VIAL | 1 vial | 2021-03-26 | 0000-00-00 | No | No | Current |